Form 4 for LH Labcorp
Accepted 2025-02-13 00:00:00 ET · period of report 2025-02-11 · accession 0001127602-25-004543 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-13 | 2025-02-11 | LH | Schechter Adam H | Pres, CEO, Dir | S - Sale+OE | $244.62 | -6,121 | 86.4K | -7% | -$1.50M |
| D | 2025-02-13 | 2025-02-11 | LH | Schechter Adam H | Pres, CEO, Dir | M - OptEx | — | +2,963 | 89.4K | +3% | — |
| D | 2025-02-13 | 2025-02-11 | LH | Schechter Adam H | Pres, CEO, Dir | F - Tax | $245.14 | -1,226 | 88.2K | -1% | -$300.5K |
| DM | 2025-02-13 | 2025-02-11 | LH | Schechter Adam H | Pres, CEO, Dir | A - Grant | $0.00 | +44.1K | 26.1K | New | $0 |
| D | 2025-02-13 | 2025-02-11 | LH | Schechter Adam H | Pres, CEO, Dir | M - OptEx | $0.00 | -2,963 | 23.1K | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-11 | S | D | 6,121 | $244.62 | 86,445 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-11 | M | A | 2,963 | — | 89,408 | D | — | — | (F2) Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. |
| 3 | Common | Common Stock | 2025-02-11 | F | D | 1,226 | $245.14 | 88,182 | D | — | — | |
| 4 | Derivative | Non-qualified Stock Options | 2025-02-11 | A | A | 33,100 | $0.00 | 33,100 | D | $245.14 · 2026-02-11 to 2035-02-10 | 33,100 Common Stock | (F4) Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan. (F5) The option vests in three equal annual installments beginning on the date reflected in this column. |
| 5 | Derivative | Restricted Stock Unit | 2025-02-11 | A | A | 10,970 | $0.00 | 26,102 | D | — · — to — | 10,970 Common Stock | (F7) This number reflects the aggregate number of Restricted Stock Units held by the reporting person. (F2) Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. (F6) The Restricted Stock Units vest in three equal annual installments beginning on February 11, 2026. |
| 6 | Derivative | Restricted Stock Unit | 2025-02-11 | M | D | 2,963 | $0.00 | 23,139 | D | — · — to — | 2,963 Common Stock | (F7) This number reflects the aggregate number of Restricted Stock Units held by the reporting person. (F2) Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. (F8) The Restricted Stock Units vested in three equal annual installments beginning on February 11, 2023 and are now fully vested. |